This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American I tried something new! Instead of drawing a ...

This Poster will be available on the Company’s website on the “Publications: Posters & Presentations” page under the “Our Science” tab.

TORONTO--(BUSINESS WIRE)--Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction ...

DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes (T2D). Agonism of GPR119 in ...